Medtronic/$MDT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medtronic
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Ticker
$MDT
Sector
Primary listing
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Galway, Ireland
Employees
95,000
Website
Medtronic Metrics
BasicAdvanced
$118B
25.49
$3.61
0.81
$2.81
3.09%
Price and volume
Market cap
$118B
Beta
0.81
52-week high
$96.25
52-week low
$78.32
Average daily volume
7.8M
Dividend rate
$2.81
Financial strength
Current ratio
1.849
Quick ratio
1.202
Long term debt to equity
53.137
Total debt to equity
61.393
Dividend payout ratio (TTM)
76.98%
Interest coverage (TTM)
8.78%
Profitability
EBITDA (TTM)
9,560
Gross margin (TTM)
65.51%
Net profit margin (TTM)
13.90%
Operating margin (TTM)
19.97%
Effective tax rate (TTM)
16.63%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
4.61%
Return on equity (TTM)
9.51%
Valuation
Price to earnings (TTM)
25.488
Price to revenue (TTM)
3.527
Price to book
2.46
Price to tangible book (TTM)
-21.92
Price to free cash flow (TTM)
22.814
Free cash flow yield (TTM)
4.38%
Free cash flow per share (TTM)
403.31%
Dividend yield (TTM)
3.05%
Forward dividend yield
3.09%
Growth
Revenue change (TTM)
3.62%
Earnings per share change (TTM)
30.80%
3-year revenue growth (CAGR)
1.91%
10-year revenue growth (CAGR)
5.17%
3-year earnings per share growth (CAGR)
-1.08%
10-year earnings per share growth (CAGR)
4.12%
3-year dividend per share growth (CAGR)
3.57%
10-year dividend per share growth (CAGR)
8.66%
What the Analysts think about Medtronic
Analyst ratings (Buy, Hold, Sell) for Medtronic stock.
Medtronic Financial Performance
Revenues and expenses
Medtronic Earnings Performance
Company profitability
Medtronic News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medtronic stock?
Medtronic (MDT) has a market cap of $118B as of July 25, 2025.
What is the P/E ratio for Medtronic stock?
The price to earnings (P/E) ratio for Medtronic (MDT) stock is 25.49 as of July 25, 2025.
Does Medtronic stock pay dividends?
Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of July 25, 2025, the dividend rate is $2.81 and the yield is 3.09%. Medtronic has a payout ratio of 76.98% on a trailing twelve-month basis.
When is the next Medtronic dividend payment date?
The next Medtronic (MDT) dividend payment date is unconfirmed.
What is the beta indicator for Medtronic?
Medtronic (MDT) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.